Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    The influence of Gleason score ≤ 6 histology on the outcome of high-risk localized prostate cancer after modern radiotherapy

    We aimed to retrospectively review outcomes in patients with high-risk prostate cancer and a Gleason score ≤ 6 following modern radiotherapy. We analyzed the outcomes of 1374 patients who had undergone modern ...

    Hideya Yamazaki, Gen Suzuki, Koji Masui, Norihiro Aibe, Takuya Kimoto in Scientific Reports (2024)

  2. Article

    Correction to: Immunological risk and complement genetic evaluations in early onset de novo thrombotic microangiopathy after living donor kidney transplantation: A Japanese multicenter registry

    Nobuhiro Fujiyama, Masayuki Tasaki, Hiroshi Harada in Clinical and Experimental Nephrology (2023)

  3. No Access

    Article

    Immunological risk and complement genetic evaluations in early onset de novo thrombotic microangiopathy after living donor kidney transplantation: A Japanese multicenter registry

    Thrombotic microangiopathy (TMA) after kidney transplantation (KTx), particularly early onset de novo (dn) TMA, requires immediate interventions to prevent irreversible organ damage. This multicenter study was...

    Nobuhiro Fujiyama, Masayuki Tasaki, Hiroshi Harada in Clinical and Experimental Nephrology (2023)

  4. Article

    Open Access

    Treatment impact of newly approved therapeutic agents for metastatic urothelial carcinoma in Japan: a single-center retrospective study

    Although recent clinical trials of new therapeutic agents for metastatic urothelial carcinoma have shown prolonged overall survival, there are few real-world evidence. To assess the impact of new therapeutic a...

    Yuta Inoue, Takeshi Yamada, Atsuko Fujihara, Masatsugu Miyashita in Scientific Reports (2023)

  5. Article

    Open Access

    Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab

    Immune checkpoint inhibitors (ICIs) have been approved for the treatment of metastatic renal cell carcinoma (mRCC). However, the response rate is still limited, and it is urgent to pursue novel and concise mar...

    Soichi Matsumura, Taigo Kato, Yuma Kujime, Hiroaki Kitakaze, Kosuke Nakano in BMC Urology (2023)

  6. No Access

    Article

    Surgical and functional outcomes of robot-assisted laparoscopic partial nephrectomy for renal cell carcinoma in adolescents and young adults: a propensity score matching study

    Cancer development in adolescents and young adults (AYAs) has elicited recent interest. We investigated the surgical and functional outcomes of robot-assisted laparoscopic partial nephrectomy (RAPN) for renal ...

    Kazuhiko Yoshida, Tsunenori Kondo in International Journal of Clinical Oncology (2022)

  7. No Access

    Article

    Comparisons of surgical outcomes between transperitoneal and retroperitoneal approaches in robot-assisted laparoscopic partial nephrectomy for lateral renal tumors: a propensity score-matched comparative analysis

    To compare the surgical outcomes between the transperitoneal (TP) and retroperitoneal (RP) approaches in robot-assisted laparoscopic partial nephrectomy (RAPN) for lateral tumors.

    Toshio Takagi, Kazuhiko Yoshida, Tsunenori Kondo in Journal of Robotic Surgery (2021)

  8. Article

    Open Access

    Correction to: Total nephroureterocystectomy and urethrectomy due to urothelial carcinoma associated with the BK polyomavirus infection after kidney transplantation: a case report with literature review

    An amendment to this paper has been published and can be accessed via the original article.

    Ryoichi Maenosono, Masayoshi Okumi, Kohei Unagami in Renal Replacement Therapy (2020)

  9. Article

    Open Access

    Total nephroureterocystectomy and urethrectomy due to urothelial carcinoma associated with the BK polyomavirus infection after kidney transplantation: a case report with literature review

    BK polyomavirus (BKPyV) infection after kidney transplantation is an important cause of graft failure among kidney transplant recipient and may cause malignant tumor, although the association between BKPyV inf...

    Ryoichi Maenosono, Masayoshi Okumi, Kohei Unagami in Renal Replacement Therapy (2020)

  10. No Access

    Article

    Clinical outcomes of repeat partial nephrectomy compared to initial partial nephrectomy of a solitary kidney

    When local recurrence of renal cell carcinoma (RCC) occurs after nephron-sparing surgery (NSS) on the ipsilateral side, some surgeons hesitate to perform reoperative surgery because of possible difficulties. W...

    Kazuhiko Yoshida, Tsunenori Kondo in International Journal of Clinical Oncology (2020)

  11. No Access

    Article

    Predictive factors for recurrence after partial nephrectomy for clinical T1 renal cell carcinoma: a retrospective study of 1227 cases from a single institution

    Identifying the predictive factors for tumor recurrence after partial nephrectomy (PN) is useful to determine patients who require careful observation after surgery. Therefore, we investigated recurrence after...

    Toshio Takagi, Kazuhiko Yoshida, Arisa Wada in International Journal of Clinical Oncology (2020)

  12. No Access

    Article

    Comparable efficacy and safety between second-line and later-line nivolumab therapy for metastatic renal cell carcinoma

    The aim of this study was to compare the efficacy and safety of nivolumab as second-line and later-line (third-line or thereafter) therapy in metastatic renal cell carcinoma (mRCC).

    Hiroki Ishihara, Toshio Takagi in International Journal of Clinical Oncology (2020)

  13. No Access

    Article

    Effect of renin–angiotensin system blockade on graft survival and cardiovascular disease in kidney transplant recipients: retrospective multicenter study in Japan

    Renin–angiotensin system blockers (RASBs) reduce end-stage kidney disease and cardiovascular event (CVE) development in chronic kidney disease. However, whether RASBs improve long-term prognosis in kidney tran...

    Akihiro Tsuchimoto, Kosuke Masutani, Kenji Ueki in Clinical and Experimental Nephrology (2020)

  14. No Access

    Article

    Pure versus hand-assisted retroperitoneoscopic live donor nephrectomy: a retrospective cohort study of 1508 transplants from two centers

    Although minimally invasive procedures have been established as the standard for a donor nephrectomy, there are many different surgical techniques described in the literature. The aim of this study is to compa...

    Hiroshi Noguchi, Yoichi Kakuta, Masayoshi Okumi, Kazuya Omoto in Surgical Endoscopy (2019)

  15. No Access

    Article

    Development and validation of a new prediction model for graft function using preoperative marginal factors in living-donor kidney transplantation

    Recently, living-donor kidney transplantation from marginal donors has been increasing. However, a simple prediction model for graft function including preoperative marginal factors is limited. Here, we develo...

    Yuta Matsukuma, Kosuke Masutani, Shigeru Tanaka in Clinical and Experimental Nephrology (2019)

  16. No Access

    Article

    The interaction between post-transplant anemia and allograft function in kidney transplantation: The Japan Academic Consortium of Kidney Transplantation-II study

    The interaction between post-transplant anemia (PTA) and allograft function in kidney transplantation has not been evaluated directly. PTA, defined by WHO/AST criteria, was investigated in 1307 adult kidney tr...

    Masayoshi Okumi, Yasuhiro Okabe, Kohei Unagami in Clinical and Experimental Nephrology (2019)

  17. No Access

    Article

    Predictive Impact of Peripheral Blood Markers and C-Reactive Protein in Nivolumab Therapy for Metastatic Renal Cell Carcinoma

    Predictive factors that can be routinely used in clinical practice are critically needed for immune checkpoint inhibitor therapy in metastatic renal cell carcinoma (mRCC).

    Hiroki Ishihara, Hidekazu Tachibana, Toshio Takagi, Tsunenori Kondo in Targeted Oncology (2019)

  18. No Access

    Article

    Combination therapy of an iNKT cell ligand and CD40–CD154 blockade establishes islet allograft acceptance in nonmyeloablative bone marrow transplant recipients

    Islet transplantation is an effective therapeutic option for type 1 diabetes. Although maintenance immunosuppression therapy is required to prevent allogeneic rejection and recurrence of autoimmunity, long-ter...

    Taichi Kanzawa, Toshihito Hirai, Hironori Fukuda, Haruki Katsumata in Acta Diabetologica (2019)

  19. No Access

    Article

    Kidney transplantation for treatment of end-stage kidney disease after haematopoietic stem cell transplantation: case series and literature review

    The safety of kidney transplantation (KT) for end-stage kidney disease (ESKD) after haematopoietic stem cell transplantation (HSCT) for haematological disease has not been investigated thoroughly.

    Akihiro Tsuchimoto, Kosuke Masutani, Kazuya Omoto in Clinical and Experimental Nephrology (2019)

  20. No Access

    Article

    Prognostic Markers for Refined Stratification of IMDC Intermediate-Risk Metastatic Clear Cell Renal Cell Carcinoma Treated with First-Line Tyrosine Kinase Inhibitor Therapy

    Patients in the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) intermediate-risk group have heterogeneous prognoses and thus may benefit from improved risk stratification.

    Toshio Takagi, Hironori Fukuda, Tsunenori Kondo, Hiroki Ishihara in Targeted Oncology (2019)

previous disabled Page of 2